Medical/Pharmaceuticals News & Press Release Distribution

VARON Reiterates Its Commitment to Brand Value and Its Determination to Reshape the Oxygen Concentrator Industry

SEATTLE, July 28, 2023 /PRNewswire/ -- VARON has built a strong brand reputation by consistently providing practical and preferential oxygen concentrators that improve the lives of individuals with respiratory conditions. By optimizing products and services, VARON continue...

2023-07-28 22:20 2596

Latest Updates of 7 Viva's Portfolio Companies

HONG KONG, July 28, 2023 /PRNewswire/ -- In the face of ever-changing circumstances, technological innovation remains the eternal driving force behind the long-term growth of biopharmaceutical companies. It continuously breathes life into these enterprises, enabling them to successfully transitio...

2023-07-28 19:31 6254

HANQUYOU Marks 3rd Anniversary with Brilliant Achievements

* HANQUYOU is the China-developed biosimilar with the most marketing approvals, covering 41 countries and regions * The launch of HANQUYOU kicks off the competition between Chinese pharmaceutical companies and the world's bio-pharmaceutical companies in biosimilar monoclonal antibodies * He...

2023-07-28 15:53 3509

HANQUYOU Marks 3rd Anniversary with Brilliant Achievements

* HANQUYOU is the China-developed biosimilar with the most marketing approvals, covering 41 countries and regions * The launch of HANQUYOU kicks off the competition between Chinese pharmaceutical companies and the world's bio-pharmaceutical companies in biosimilar monoclonal antibodies * He...

2023-07-28 15:27 2766

Wuan Ankang Hospital's Innovative Tumor Treatment Attracts Many Patients

HANDAN, China, July 28, 2023 /PRNewswire/ -- In Handan City, Hebei Province, China, the Wu'an Ankang Hospital has 35-year of experience with tumor treatment. It has now become a second-class general hospital. The reason it attracts many patients from bothChina and abroad is that they practice hol...

2023-07-28 14:35 1241

Eeva Medical Aesthetic Clinic moves to brand new location at Raffles Place, launches fresh website

Ushering in a new era of growth, Eeva Aesthetics focuses all efforts on bringing game-changing technology to the medical aesthetic space, starting with expanding EMFACE inSingapore. SINGAPORE, July 28, 2023 /PRNewswire/ -- Eeva Medical Aesthetic Clinic launches their brand new space in the heart...

2023-07-28 13:13 2306

BPEA EQT to acquire a majority stake in Indira IVF - India's largest chain of fertility clinics

* BPEA EQT to acquire a majority stake in Indira IVF, the largest provider of fertility services inIndia and top five globally in terms of annual IVF cycles, having facilitated 125,000 successful pregnancies to date * India is one of the fastest growing markets globally for Assisted Reproduct...

2023-07-28 12:11 1890

GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

– Gilead expands the ALL4LIVER Grant, Providing Grant Funding to Organizations inAfrica, South America, Asia and Oceania, Europe and North America – – Themed 'Test. Link. Prioritize', the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 – SINGAPORE, July 28, ...

2023-07-28 12:00 5425

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

HONG KONG, Germantown, Md. and SUZHOU, China, July 28, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced tha...

2023-07-28 11:56 2311

Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch

Pioneering Green Energy Solutions: DrSignal Biotech and J&V Energy's Promising Alliance TAIPEI, July 27, 2023 /PRNewswire/ -- At the 2022 Healthcare Expo Taiwan, Dr.Signal Biotech showcased the remarkable 3A-GTP technology, succeeding a significant breakthrough. This technology accelerates the p...

2023-07-28 10:00 1455

Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch

61.6 percent of Young Thai Women Put off by Pap Smears: BGI Genomics Cervical Cancer Survey

* 61.6% of Thai women aged 21-25 years deterred by pap smears which is higher than the global average of 43.5% HONG KONG, July 28, 2023 /PRNewswire/ -- Only 28.5% of Thai women are diagnosed at stage I of cervical cancer when survival rates are highest, according to a study

2023-07-28 08:37 1515

61.6 percent of Young Thai Women Put off by Pap Smears: BGI Genomics Cervical Cancer Survey

Nutromics attracts world leaders in the emerging field of DNA-based sensing to join its Biosensor Advisory Board

MELBOURNE, Australia, July 28, 2023 /PRNewswire/ -- Nutromics has announced today that its lab-on-a-patch technology has attracted the support of multiple world-class experts from leading US and Australian institutions, who now comprise its Biosensor Advisory Board. Nutromics is a leader in conti...

2023-07-28 08:27 1873

TraceLink Accelerates DSCSA 2023 Customer Readiness, Supply Chain Digitalization, and Drug Shortage Predictability in Second Quarter of 2023

As the industry prepares for DSCSA 2023 regulations, 50% of the US MAH market is now EPCIS-enabled through the TraceLink B2N Integrate-Once network. This digital foundation is allowing them to enhance supply chain visibility, collaboration, and resilience. BOSTON, July 28, 2023 /PRNewswire/ -- T...

2023-07-28 05:48 1925

World Hepatitis Alliance raise awareness of viral hepatitis on World Hepatitis Day as research shows hepatitis B and C cause significantly higher cancer risk than smoking a daily pack of cigarettes

LONDON, July 28, 2023 /PRNewswire/ -- Today, World Hepatitis Day (WHD) launches with the call to action 'We're not waiting'. On WHD, the World Hepatitis Alliance (WHA) joins together with its global network of 323 members in over 100 countries to lead the campaign internationally to accelerate th...

2023-07-28 04:02 2094

HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update

* Sales recorded KRW 41.4 billion, a 58 percent increase from the same period in 2022, due to sustained robust growth of major products in addition to milestone revenues from the progress in clinical programs of batoclimab. * Multiple clinical development milestones have been reached, includin...

2023-07-27 19:00 1976

NEC Thailand and Thammasat Thammarak Center to trial digital health platform

BANGKOK, July 27, 2023 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand), has signed a Memorandum of Understanding (MoU) withThammasat University Hospital to collaborate on the development of a digital platform aimed at supporting the hospital's healthcare system.

2023-07-27 16:41 2270

NEC Thailand and Thammasat Thammarak Center to trial digital health platform

Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights

New data captures German prescribing insights providing researchers with aggregated, anonymised specialty prescribing habits across brands and diseases LONDON, July 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they ca...

2023-07-27 15:00 1715

AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine

- AIM Is First Japanese Company to Establish Joint Research Agreement in Field of Endoscopic AI - TOKYO, July 27, 2023 /PRNewswire/ -- AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement ...

2023-07-27 14:00 1247

Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award

Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market. SAN ANTONIO, July 27, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...

2023-07-27 14:00 1545

Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress

TAIZHOU, China, July 27, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Board") is pleased to announce that the Group has recently received the notice of acceptance (acceptance number: CXSL2300518) issued by National Medical Products Administration ("NMPA"), pursuant to which the c...

2023-07-27 10:57 4414